These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 3451197

  • 1. [Results of the treatment of patients with Hodgkin's disease by the MOPP protocol in relation to the histological type of the disease].
    Krajewska B, Dziewulska-Bokiniec A, Goszczyńska-Matysiak E, Kacprzak G.
    Nowotwory; 1987; 37(4):317-21. PubMed ID: 3451197
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The role of MOPP chemotherapy in early stage Hodgkin's disease.
    Mauch P, Hellman S.
    Hematol Oncol; 1984; 2(1):66-9. PubMed ID: 6376318
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of Hodgkin's disease in children with alternating mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) and adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) courses without radiotherapy.
    van den Berg H, Stuve W, Behrendt H.
    Med Pediatr Oncol; 1997 Jul; 29(1):23-7. PubMed ID: 9142201
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. MOPP/ABVD chemotherapy for advanced Hodgkin's disease.
    Glick JH, Tsiatis A.
    Ann Intern Med; 1986 Jun; 104(6):876-8. PubMed ID: 2422998
    [No Abstract] [Full Text] [Related]

  • 15. MOPP, ABVD, or both to treat Hodgkin's disease.
    Aisenberg AC.
    N Engl J Med; 1993 Apr 08; 328(14):1045; author reply 1045-6. PubMed ID: 7680765
    [No Abstract] [Full Text] [Related]

  • 16. Randomised study of MOPP (mustine, Oncovin, procarbazine, prednisone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease. British National Lymphoma Investigation.
    Hancock BW.
    Radiother Oncol; 1986 Nov 08; 7(3):215-21. PubMed ID: 3544084
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of Hodgkin's disease including the staging laparotomy].
    Yosida T, Nakanisi J, Kobayasi S, Ohtake S, Ito K, Nakamura S, Hattori K, Saito Y, Tanimoto K.
    Rinsho Ketsueki; 1984 Jun 08; 25(6):827-34. PubMed ID: 6548266
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. British National Lymphoma Investigation randomised study of MOPP (mustine, Oncovin, procarbazine, prednisolone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease--long term results.
    Hancock BW, Vaughan Hudson G, Vaughan Hudson B, Haybittle JL, Bennett MH, MacLennan KA, Jelliffe AM.
    Br J Cancer; 1991 Apr 08; 63(4):579-82. PubMed ID: 2021542
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.